- Zacks•last month
CTI BioPharma (CTIC) could be good choice for investors as it is seeing decent short-term momentum and positive earnings estimate revisions.
- Zacks•2 months ago
CTI BioPharma has actually seen rising estimates over the past one month and looks well positioned for a solid gain, but has been overlooked by investors.
|52wk Range||0.23 - 1.75|
|Day's Range||0.33 - 0.34|
|Avg Vol (3m)||1,115,716|
As of 7:55 AM EDT. Milan Delayed Price. Market open.